Registry of Toxic Effects of Chemical Substances (RTECS)
Arsenic
RTECS #
CG0525000CAS #
7440-38-2Updated
December 2013Molecular Weight
74.92Molecular Formula
AsSynonyms
Arsen (German,Polish)Arsenic (ACGIH:OSHA)
Arsenic Black
Arsenic, elemental
Arsenic-75
Arsenicals
Colloidal arsenic
Grey arsenic
Inorganic arsenic
Metallic arsenic
Mutation Data and Reference
System Test | Route/Organism/Tissue | Dose | Reference |
---|---|---|---|
Cytogenetic Analysis | unreported route/human | 4286 µg/kg | HUGEDQ 48,1,1979 |
Cytogenetic Analysis | oral/mouse | 280 mg/kg/8W | MUREAV 113,293,1983 |
Cytogenetic Analysis | oral/human | 0.211 mg/L/15Y | MUREAV 534,133,2003 |
Cytogenetic Analysis | lung/human | 5 µmol/L | TOXID9 44,31,2005 |
Cytogenetic Analysis | lymphocyte/human | 131.90 µg/L | MUTAEX 19,223,2004 |
DNA Damage | fibroblast/mouse | 5 nmol/L/24H | TOXID9 44,237,2005 |
DNA Damage | lung/human | 5 µmol/L | TOXID9 72,219,2003 |
DNA Damage | lymphocyte/human | 5 µmol/L/1H | TOXID9 12,430,2008 |
micronucleus test | multiple/other fish | 451.40 ppb/15D-continuous | MUTAEX 20,291,2005 |
sister chromatid exchange | oral/human | 0.211 mg/L/15Y | MUREAV 534,133,2003 |
Reproductive Effects Data and References
Route/Organism | Dose | Effect | Reference |
---|---|---|---|
oral/rat | 605 µg/kg (35W prior to copulation) | Reproductive: Effects on fertility: Pre- implantation mortality (e.g., reduction in number of implants per female; total number of implants per corpora lutea) Reproductive: Effects on fertility: Post- implantation mortality (e.g., dead and/or resorbed implants per total number of implants) | GISAAA 42(8),30,1977 |
oral/rat | 580 µg/kg (30W prior to copulation/1-20D pregnant) | Reproductive: Specific developmental abnormalities: Musculoskeletal system | FATOAO 41,620,1978 |
oral/mouse | 187 mg/kg (8-18D pregnant) | Reproductive: Specific developmental abnormalities: Hepatobiliary system | TOXID9 72,214,2003 |
Tumorigenic Data and References
Route/Organism | Dose | Effect | Reference |
---|---|---|---|
implant/rabbit | lowest published toxic dose: 75 mg/kg | Tumorigenic: Equivocal tumorigenic agent by RTECS criteria Lung, Thorax, or Respiration: Tumors Liver: Tumors | ZEKBAI 52,425,1942 |
oral/man | lowest published toxic dose: 76 mg/kg/12Y- intermittent | Tumorigenic: Carcinogenic by RTECS criteria Liver: Tumors Blood: Hemorrhage | RMCHAW 99,664,1971 |
Acute Toxicity Data and References
Route/Organism | Dose | Effect | Reference |
---|---|---|---|
intraperitoneal/guinea pig | lowest published lethal dose: 10 mg/kg | Liver: Fatty liver degeneration Kidney, Ureter, and Bladder: Other changes | CRSBAW 81,164,1918 |
intraperitoneal/mouse | lethal dose (50 percent kill): 46200 µg/kg | Behavioral: Ataxia Gastrointestinal: Hypermotility, diarrhea | GTPZAB 31(12),53,1987 |
intraperitoneal/mouse | lethal dose (50 percent kill): 1000 mg/kg | VCVN5* -,87,1993 | |
intraperitoneal/mouse | lowest published toxic dose: 1 mg/kg | Liver: Other changes Biochemical: Metabolism (intermediary): Lipids including transport Biochemical: Metabolism (intermediary): Other proteins | TOXID9 -,293,2008 |
intraperitoneal/rat | lethal dose (50 percent kill): 13390 µg/kg | TXCYAC 64,191,1990 | |
oral/child | lowest published toxic dose: 4 mg/kg | Cardiac: EKG changes not diagnostic of above Blood: Changes in leukocyte (WBC) count Nutritional and Gross Metabolic: Changes in: Metabolic acidosis | PECAE5 13,394,1997 |
oral/man | lowest published toxic dose: 7857 mg/kg/55Y | Gastrointestinal: Changes in structure or function of esophagus Blood: Hemorrhage Skin: After systemic exposure: Dermatitis, other | CMAJAX 120,168,1979 |
oral/mouse | lethal dose (50 percent kill): 144 mg/kg | VCVN5* -,87,1993 | |
oral/mouse | lethal dose (50 percent kill): 145 mg/kg | Behavioral: Ataxia Gastrointestinal: Hypermotility, diarrhea | GTPZAB 31(12),53,1987 |
oral/rat | lethal dose (50 percent kill): 763 mg/kg | Behavioral: Ataxia Gastrointestinal: Hypermotility, diarrhea | GTPZAB 31(12),53,1987 |
oral/rat | lethal dose (50 percent kill): 763 mg/kg | ENTOX* -,168,2005 | |
oral/rat | lowest published toxic dose: 5 mg/kg | Brain and Coverings: Other degenerative changes | TXCYAC 235,73,2007 |
subcutaneous/guinea pig | lowest published lethal dose: 300 mg/kg | ASBIAL 24,442,1938 | |
subcutaneous/rabbit | lowest published lethal dose: 300 mg/kg | ASBIAL 24,442,1938 | |
Tank with water/Daphnia | lethal concentration (50 percent kill): 2850 µg/L/48H | TIVIEQ 31,125,1995 |
Other Multiple Dose Data and References
Route/Organism | Dose | Effect | Reference |
---|---|---|---|
oral/mouse | lowest published toxic dose: 280 mg/kg/4W- continuous | Immunological Including Allergic: Uncharacterized (multiple organ involvement) | TOXID9 72,376,2003 |
oral/mouse | lowest published toxic dose: 0.35 mg/kg/5W- continuous | Biochemical: Metabolism (intermediary): Other | TOXID9 44,32,2005 |
oral/mouse | lowest published toxic dose: 0.07 µg/kg/5W- continuous | Liver: Other changes Endocrine: Other changes Biochemical: Metabolism (intermediary): Other proteins | TOXID9 -,293,2008 |
oral/mouse | lowest published toxic dose: 0.7 µg/kg/5W- continuous | Liver: Other changes Biochemical: Metabolism (intermediary): Lipids including transport Biochemical: Metabolism (intermediary): Other proteins | TOXID9 -,293,2008 |
oral/mouse | lowest published toxic dose: 18.2 mg/kg/13W- continuous | Vascular: Structural changes in vessels Blood: Changes in serum composition (e.g. TP, bilirubin, cholesterol) Biochemical: Metabolism (intermediary): Lipids including transport | TOXID9 12,405,2008 |
oral/mouse | lowest published toxic dose: 1783.6 mg/kg/26W- continuous | Vascular: Structural changes in vessels Blood: Changes in serum composition (e.g. TP, bilirubin, cholesterol) Biochemical: Metabolism (intermediary): Effect on inflammation or mediation of inflammation | TOXID9 12,405,2008 |
oral/rat | lowest published toxic dose: 1360 mg/kg/17D- intermittent | Gastrointestinal: Other changes Kidney, Ureter, and Bladder: Interstitial nephritis Blood: Changes in cell count (unspecified) | GTPZAB 31(12),53,1987 |
Reviews
Organization | Standard | Reference |
---|---|---|
American Conference of Governmental Industrial Hygienists (ACGIH) | Threshold Limit Value-time-weighted average 0.01 mg/m3 | DTLVS* TLV/BEI,2013 |
American Conference of Governmental Industrial Hygienists (ACGIH) | Threshold Limit Value-Confirmed human carcinogen | DTLVS* TLV/BEI,2013 |
International Agency for Research on Cancer (IARC) | Cancer Review:Human Sufficient Evidence | IMEMDT 23,39,1980 |
International Agency for Research on Cancer (IARC) | Cancer Review:Animal Limited Evidence | IMSUDL 7,100,1987 |
International Agency for Research on Cancer (IARC) | Cancer Review:Human Inadequate Evidence | IMEMDT 2,48,1973 |
International Agency for Research on Cancer (IARC) | Cancer Review:Group 1 | IMSUDL 7,100,1987 |
TOXICOLOGY REVIEW | EVHPAZ 110,883,2002 | |
TOXICOLOGY REVIEW | EVHPAZ 110,767,2002 | |
TOXICOLOGY REVIEW | JAVMA4 164,277,1974 | |
TOXICOLOGY REVIEW | CTOXAO 5,151,1972 | |
TOXICOLOGY REVIEW | ARPTDI 16,95,1976 | |
TOXICOLOGY REVIEW | KOTTAM 11,1300,1975 | |
TOXICOLOGY REVIEW | FOREAE 7,313,1942 | |
TOXICOLOGY REVIEW | AQMOAC #73-19,1973 | |
TOXICOLOGY REVIEW | PTPAD4 1,189,1976 | |
TOXICOLOGY REVIEW | CLCHAU 19,361,1973 | |
TOXICOLOGY REVIEW | 85CVA2 5,63,1970 | |
TOXICOLOGY REVIEW | PEXTAR 12,102,1969 | |
TOXICOLOGY REVIEW | JOCMA7 2,137,1960 | |
TOXICOLOGY REVIEW | BNYMAM 54,413,1978 | |
TOXICOLOGY REVIEW | AMTODM 3,209,1977 | |
TOXICOLOGY REVIEW | EVHPAZ 19,179,1977 | |
TOXICOLOGY REVIEW | TOLED5 127,63,2002 | |
TOXICOLOGY REVIEW | TOLED5 134,39,2002 | |
TOXICOLOGY REVIEW | TOLED5 134,3,2002 | |
TOXICOLOGY REVIEW | MUREAV 589,111,2005 | |
TOXICOLOGY REVIEW | 85CVA2 5,250,1970 | |
TOXICOLOGY REVIEW | TOLED5 128,69,2002 | |
TOXICOLOGY REVIEW | CREOH* 42,93,2002 | |
TOXICOLOGY REVIEW | TOLED5 145,1,2003 | |
TOXICOLOGY REVIEW | MUREAV 567,109,2004 | |
TOXICOLOGY REVIEW | REPTED 22,164,2006 | |
TOXICOLOGY REVIEW | ENTOX* -,168,2005 | |
TOXICOLOGY REVIEW | TOPADD 31,575,2003 | |
TOXICOLOGY REVIEW | TOPADD 33,63,2005 | |
TOXICOLOGY REVIEW | TOPADD 32(Suppl. 2),71,2004 | |
TOXICOLOGY REVIEW | MUREAV 544,243,2003 | |
TOXICOLOGY REVIEW | MUREAV 659,93,2008 | |
TOXICOLOGY REVIEW | MUREAV 544,313,2003 | |
TOXICOLOGY REVIEW | HTOPA* 1,701,2002 | |
TOXICOLOGY REVIEW | HUTOX* -,247,1996 | |
TOXICOLOGY REVIEW | MUREAV 681,93,2009 | |
TOXICOLOGY REVIEW | FCTOD7 46,813,2008 | |
TOXICOLOGY REVIEW | MUREAV 674,3,2009 | |
TOXICOLOGY REVIEW | MUREAV 674,31,2009 | |
TOXICOLOGY REVIEW | MUREAV 674,73,2009 | |
TOXICOLOGY REVIEW | MUREAV 667,82,2009 | |
TOXICOLOGY REVIEW | BLREV* 3,71,1989 | |
TOXICOLOGY REVIEW | AEXHE* -,407,1999 | |
TOXICOLOGY REVIEW | AEXHE* -,123,1999 | |
TOXICOLOGY REVIEW | AEXHE* -,133,1999 | |
TOXICOLOGY REVIEW | DERCL* 25,215,2007 | |
TOXICOLOGY REVIEW | NEUCL* 15,711,1997 | |
TOXICOLOGY REVIEW | NEUCL* 23,377,2005 | |
TOXICOLOGY REVIEW | NTAPM* -,617,1995 | |
TOXICOLOGY REVIEW | NTAPM* -,629,1995 | |
TOXICOLOGY REVIEW | NTAPM* -,689,1995 | |
TOXICOLOGY REVIEW | NTAPM* -,695,1995 | |
TOXICOLOGY REVIEW | NTAPM* -,711,1995 | |
TOXICOLOGY REVIEW | NTAPM* -,737,1995 | |
TOXICOLOGY REVIEW | MUTAEX 23,191,2008 | |
TOXICOLOGY REVIEW | MUREAV 705,165,2010 | |
TOXICOLOGY REVIEW | MUREAV 705,130,2010 | |
TOXICOLOGY REVIEW | MUREAV 705,172,2010 | |
TOXICOLOGY REVIEW | TOLED5 192,45,2010 | |
TOXICOLOGY REVIEW | REPTED 31,327,2011 | |
TOXICOLOGY REVIEW | MUREAV 705,11,2010 | |
TOXICOLOGY REVIEW | MUTAEX 26,51,2011 | |
TOXICOLOGY REVIEW | REPTED 31,363,2011 | |
TOXICOLOGY REVIEW | MUREAV 714,105,2011 | |
TOXICOLOGY REVIEW | MUREAV 728,88,2011 | |
TOXICOLOGY REVIEW | MUREAV 746,104,2012 | |
TOXICOLOGY REVIEW | REPTED 35,165,2013 | |
TOXICOLOGY REVIEW | EMMUEG 49,9,2008 | |
TOXICOLOGY REVIEW | MUTAEX 27,257,2012 | |
TOXICOLOGY REVIEW | MUREAV 746,113,2012 |
Standards and Regulations
Organization | Standard | Reference |
---|---|---|
Mine Safety and Health Administration (MSHA) STANDARD-air | time-weighted average 0.5 mg/m3 | DTLVS* 3,16,1971 |
Occupational Exposure Limit IN ARGENTINA, BULGARIA, COLOMBIA, JORDAN check ACGIH TLV; | ||
Occupational Exposure Limit IN SINGAPORE, VIETNAM check ACGIH TLV | ||
Occupational Exposure Limit-ARAB Republic of Egypt | time-weighted average 0.2 mg/m3, JAN1993 | |
Occupational Exposure Limit-AUSTRALIA | time-weighted average 0.05 mg/m3, Carcinogen, JUL2008 | |
Occupational Exposure Limit-BELGIUM | time-weighted average 0.1 mg/m3, Carcinogen, MAR2002 | |
Occupational Exposure Limit-DENMARK | time-weighted average 0.01 mg(As)/m3, carc, MAY2011 | |
Occupational Exposure Limit-DENMARK | time-weighted average 0.01 mg/m3, carc, MAY2011 | |
Occupational Exposure Limit-FINLAND | time-weighted average 0.01 mg/m3, NOV2011 | |
Occupational Exposure Limit-HUNGARY | ceiling concentration 0.01 mg/m3, Skin, Carcinogen, SEP2000 | |
Occupational Exposure Limit-ICELAND | time-weighted average 0.01 mg(As)/m3, carc, NOV2011 | |
Occupational Exposure Limit-INDIA | time-weighted average 0.2 mg/m3, JAN1993 | |
Occupational Exposure Limit-JAPAN | 1 carc, MAY2012 | |
Occupational Exposure Limit-KOREA | time-weighted average 0.2 mg/m3, 2006 | |
Occupational Exposure Limit-MEXICO | time-weighted average 0.2 mg(As)/m3, 2004 | |
Occupational Exposure Limit-NEW ZEALAND | time-weighted average 0.05 mg(As)/m3, carcinogen, JAN2002 | |
Occupational Exposure Limit-NORWAY | time-weighted average 0.02 mg/m3, JAN1999 | |
Occupational Exposure Limit-PERU | time-weighted average 0.01 mg/m3, JUL2005 | |
Occupational Exposure Limit-POLAND | MAC(time-weighted average) 0.01 mg/m3, JAN1999 | |
Occupational Exposure Limit-SWEDEN | time-weighted average 0.01 mg/m3, Carcinogen, JUN2005 | |
Occupational Exposure Limit-THAILAND | time-weighted average 0.5 mg/m3, JAN1993 | |
Occupational Exposure Limit-THE PHILIPPINES | time-weighted average 0.5 mg/m3, JAN1993 | |
Occupational Exposure Limit-TURKEY | time-weighted average 0.5 mg/m3, JAN1993 | |
Occupational Exposure Limit-TURKEY | time-weighted average 0.5 mg(As)/m3, JAN1993 | |
Occupational Exposure Limit-UNITED KINGDOM | time-weighted average 0.1 mg/m3, carc, OCT2007 | |
Occupational Safety and Health Administration (OSHA) Permissible Exposure Limit (Construction) | 8H time-weighted average 0.5 mg(As)/m3 | CFRGBR 29,1926.55,1994 |
Occupational Safety and Health Administration (OSHA) Permissible Exposure Limit (Federal Contractors) | 8H time-weighted average 0.5 mg(As)/m3 | CFRGBR 41,50-204.50,1994 |
Occupational Safety and Health Administration (OSHA) Permissible Exposure Limit (General Industry) | 8H time-weighted average 0.5 mg(As)/m3 | CFRGBR 29,1910.1000,1994 |
Occupational Safety and Health Administration (OSHA)-cancer hazard | CFRGBR 29,1910.1018,1987 |
NIOSH Documentation and Surveillance
Organization | Standard | Reference |
---|---|---|
National Institute for Occupational Safety and Health (NIOSH) Recommended Exposure Level TO ARSENIC, INORGANIC-air | Carcinogen ceiling concentration 0.002 mg(As)/m3/15M | NIOSH* DHHS #92-100,1992 |
National Occupational Exposure Survey 1983 | Hazard Code 07545; Number of Industries 19; Total Number of Facilities 1100; Number of Occupations 29; Total Number of Employees Exposed 27275; Total Number of Female Employees Exposed 2128 | |
National Occupational Hazard Survey 1974 | Hazard Code 07545; Number of Industries 8; Total Number of Facilities 328; Number of Occupations 18; Total Number of Employees Exposed 5929 |
Status in Federal Agencies
- Page last reviewed:March 7, 2014
- Page last updated:February 6, 2017
- Content source:
- National Institute for Occupational Safety and Health (NIOSH) Education and Information Division